Vedolizumab and anti-vedolizumab antibody

Alphabetical Test listing

Vedolizumab and anti-vedolizumab antibody-994

  
Vedolizumab and anti-vedolizumab antibody
  
994
  
LAB994
  
MSO
  
Anti-integrin drug
Biological monitoring
Entyvio
Immunogenicity testing
Vedolizumab
  

Provides serum concentrations of vedolizumab and anti-vedolizumab antibodies in order to optimize treatment and facilitate clinical decision-making

  
Serum
  
  
3.0 mL
  
1.0 mL
  

Immediately following collection, thoroughly mix sample by gently inverting 5 times

  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection

 

 

  

Gold serum separator (SST) tube

  
EDTA plasma
  
  

Lavender:

Immediatley following collection, mix sample thoroughly by gentle inverting 8 - 10 times, to prevent clotting

  

Red:

  1. Allow sample to clot
  2. Spin
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection

Lavender:

  1. Spin
  2. Transfer the plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as EDTA plasma, within two (2) hours of sample collection
  
  

Ambient (preferred) - 14 days

Frozen - 14 days

Refrigerated - 14 days

 

  
  • Gross hemolysis
  • Gross lipemia
  
Esoterix Endocrinology (804567) via LabCorp (504567): R-NX
  
Weekly
  
4 - 7 days
  

Electrochemiluminescence Immunoassay (ECLIA)

  

An interpretive report will be provided

  
82397
80280
  
Result:
504568 Vedolizumab 86898-4
504569 Anti-Vedolizumab Antibody 86899-2
  
05/22/2019
  
01/02/2020